BDTX-189

· Black Diamond Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BDTX-189, covering 2025-04-17 to 2025-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors. [Phase 1]

See pricing